New cell therapy shows promise in Hard-to-Treat myeloma
NCT ID NCT05182073
First seen Jan 05, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This early-phase study tested a new treatment called FT576, given alone or with another drug (daratumumab), in 31 people whose multiple myeloma had returned or stopped responding to prior therapies. The goal was to find the safest dose and see if the combination can help control the cancer. Participants had already tried at least three other treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Medical Oncology Hematology Consultants
Newark, Delaware, 19713, United States
-
Oncology Hematology Care, Inc
Cincinnati, Ohio, 45226, United States
-
Roswell Park
Buffalo, New York, 14263, United States
-
Scri-Cbci
Denver, Colorado, 80218, United States
-
Tennessee Oncology - Nashville
Nashville, Tennessee, 37203, United States
-
Texas Oncology-Medical City Dallas
Dallas, Texas, 75230, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35205, United States
-
University of Minnesota
Saint Paul, Minnesota, 55108, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
-
Washington University
St Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.